指导冠状动脉血运重建的心肌存活检测
Myocardial Viability Testing to Guide Coronary Revascularization.
作者信息
Löffler Adrián I, Kramer Christopher M
机构信息
Division of Cardiovascular Medicine, University of Virginia Health System, Box 800170, 1215 Lee Street, Charlottesville, VA 22908, USA.
Division of Cardiovascular Medicine, University of Virginia Health System, Box 800170, 1215 Lee Street, Charlottesville, VA 22908, USA; Department of Radiology and Medical Imaging, Cardiovascular Imaging Center, University of Virginia Health System, Box 800170, 1215 Lee Street, Charlottesville, VA 22908, USA.
出版信息
Interv Cardiol Clin. 2018 Jul;7(3):355-365. doi: 10.1016/j.iccl.2018.03.005. Epub 2018 Jun 29.
Abstract
Left ventricular dysfunction remains one of the best prognostic determinants of survival in patients with coronary artery disease. Revascularization has been shown to improve survival compared with medical therapy alone. Viability testing can help direct patients who will benefit the most from revascularization. Single-photon emission computed tomography, dobutamine stress echo, cardiac MRI, and PET imaging with F18-fluorodeoxyglucose are the most common modalities for assessing myocardial viability. Viability testing can help differentiate which patients benefit most from chronic total occlusion interventions.
摘要
左心室功能障碍仍然是冠心病患者生存的最佳预后决定因素之一。与单纯药物治疗相比，血运重建已被证明可提高生存率。存活心肌检测有助于指导哪些患者将从血运重建中获益最大。单光子发射计算机断层扫描、多巴酚丁胺负荷超声心动图、心脏磁共振成像以及使用F18-氟脱氧葡萄糖的正电子发射断层显像术是评估心肌存活的最常用方法。存活心肌检测有助于区分哪些患者从慢性完全闭塞干预中获益最大。
相似文献
1
Myocardial Viability Testing to Guide Coronary Revascularization.指导冠状动脉血运重建的心肌存活检测
Interv Cardiol Clin. 2018 Jul;7(3):355-365. doi: 10.1016/j.iccl.2018.03.005. Epub 2018 Jun 29.
2
3
4
Delayed recovery of hibernating myocardium after surgical revascularization: implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability.外科血管重建术后冬眠心肌的延迟恢复：代谢成像与多巴酚丁胺超声心动图在评估心肌存活能力方面存在差异的影响因素
J Nucl Cardiol. 1999 Nov-Dec;6(6):685-7. doi: 10.1016/s1071-3581(99)90109-5.
5
Myocardial viability in patients with coronary artery disease and left ventricular dysfunction: transplantation or revascularization?冠心病合并左心室功能障碍患者的心肌存活：移植还是血运重建？
Curr Opin Cardiol. 1996 Jul;11(4):394-402. doi: 10.1097/00001573-199607000-00008.
6
Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.慢性缺血性左心室收缩功能障碍中的心肌存活成像与血运重建
Expert Rev Cardiovasc Ther. 2010 Jan;8(1):55-63. doi: 10.1586/erc.09.157.
7
Multimodality imaging in the assessment of myocardial viability.多模态影像学评估心肌活力。
Heart Fail Rev. 2011 Jul;16(4):381-95. doi: 10.1007/s10741-010-9201-7.
8
Hibernating myocardium: diagnosis and patient outcomes.冬眠心肌：诊断与患者预后
Curr Probl Cardiol. 2007 Jul;32(7):375-410. doi: 10.1016/j.cpcardiol.2007.04.001.
9
Assessment of myocardial viability: review of the clinical significance.心肌存活评估：临床意义综述
Rev Cardiovasc Med. 2008 Fall;9(4):225-31.
10
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.冠心病合并左心室功能不全患者的心肌存活能力检测及血运重建对预后的影响：一项荟萃分析
J Am Coll Cardiol. 2002 Apr 3;39(7):1151-8. doi: 10.1016/s0735-1097(02)01726-6.
引用本文的文献
1
Cardiac Magnetic Resonance Imaging in Heart Failure.心力衰竭中的心脏磁共振成像
Cardiovasc Innov Appl. 2024 Jan 3;9(1). doi: 10.15212/cvia.2024.0037. Epub 2024 Jun 27.
2
The complex role of cardiovascular imaging in viability testing.心血管成像在存活能力检测中的复杂作用。
Prog Cardiovasc Dis. 2025 Jan-Feb;88:113-125. doi: 10.1016/j.pcad.2024.12.008. Epub 2025 Jan 7.
3
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.心血管疾病管理的综合述评：心脏生物标志物、成像方式、药物治疗、手术干预和草药疗法。
Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471.
4
Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting.评估左心室收缩功能降低的缺血性心肌病患者在冠状动脉旁路移植术后的心肌存活性。
Clin Cardiol. 2024 Jul;47(7):e24307. doi: 10.1002/clc.24307.
5
Concomitant Mitral Valve Surgery Versus No Intervention in Patients with Moderate Ischemic Mitral Regurgitation Undergoing Coronary Artery Bypass Grafting: A Propensity Score Analysis.冠状动脉旁路移植术中合并中度缺血性二尖瓣反流患者行二尖瓣手术与不干预的比较：倾向评分分析
Juntendo Iji Zasshi. 2023 Feb 22;69(1):32-41. doi: 10.14789/jmj.JMJ22-0021-OA. eCollection 2023.
6
Developing and evaluating a chronic ischemic cardiomyopathy in swine model by rest and stress CMR.通过静息和负荷心脏磁共振成像在猪模型中建立和评估慢性缺血性心肌病
Int J Cardiovasc Imaging. 2024 Feb;40(2):249-260. doi: 10.1007/s10554-023-02999-4. Epub 2023 Nov 16.
7
Myocardial fibrosis in rheumatic heart disease: emerging concepts and clinical implications.风湿性心脏病中的心肌纤维化：新观点与临床意义
Front Cardiovasc Med. 2023 Jul 19;10:1230894. doi: 10.3389/fcvm.2023.1230894. eCollection 2023.
8
Artificial Intelligence Applications in Cardiovascular Magnetic Resonance Imaging: Are We on the Path to Avoiding the Administration of Contrast Media?人工智能在心血管磁共振成像中的应用：我们是否正朝着避免使用造影剂的方向发展？
Diagnostics (Basel). 2023 Jun 14;13(12):2061. doi: 10.3390/diagnostics13122061.
9
The impact of viability assessment using cardiac MRI and echocardiogram on the outcome of revascularization in patients with multi-vessels coronary artery disease and moderate to severe ischemic cardiomyopathy.心脏 MRI 和超声心动图评估存活能力对多支冠状动脉疾病合并中重度缺血性心肌病患者血运重建结局的影响。
Saudi Med J. 2023 Apr;44(4):373-378. doi: 10.15537/smj.2023.44.4.20220133.
10
Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery.抗血小板治疗在冠状动脉旁路移植术中接受冠状动脉内膜切除术的严重冠状动脉疾病患者中的作用。
J Cardiovasc Dev Dis. 2023 Mar 7;10(3):112. doi: 10.3390/jcdd10030112.
本文引用的文献
1
2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices.2017年心脏节律学会关于心血管植入式电子设备患者磁共振成像与辐射暴露的专家共识声明
Heart Rhythm. 2017 Jul;14(7):e97-e153. doi: 10.1016/j.hrthm.2017.04.025. Epub 2017 May 11.
2
Ischemia and Viability Testing in Ischemic Heart Disease: The Available Evidence and How We Interpret It.缺血性心脏病中的缺血与存活心肌检测：现有证据及我们的解读方式
JACC Cardiovasc Imaging. 2017 Mar;10(3):365-367. doi: 10.1016/j.jcmg.2017.01.005.
3
ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.美国核医学与分子影像学会（ASNC）正电子发射断层扫描（PET）核心脏病学检查的成像指南/SNMMI程序标准。
J Nucl Cardiol. 2016 Oct;23(5):1187-1226. doi: 10.1007/s12350-016-0522-3. Epub 2016 Jul 8.
4
Myocardial Viability: From Proof of Concept to Clinical Practice.心肌存活：从概念验证到临床实践
Cardiol Res Pract. 2016;2016:1020818. doi: 10.1155/2016/1020818. Epub 2016 May 29.
5
CMR Guidance for Recanalization of Coronary Chronic Total Occlusion.CMR 指导下冠状动脉慢性完全闭塞再通
JACC Cardiovasc Imaging. 2016 May;9(5):547-56. doi: 10.1016/j.jcmg.2015.10.025. Epub 2016 Apr 13.
6
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的冠状动脉搭桥手术
N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3.
7
ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.美国核医学与分子影像学会（ASNC）单光子发射计算机断层扫描（SPECT）核心脏病学检查的成像指南：负荷试验、方案及示踪剂
J Nucl Cardiol. 2016 Jun;23(3):606-39. doi: 10.1007/s12350-015-0387-x.
8
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease.冠心病患者区域性心肌变薄的发生率及其与心肌瘢痕的关系。
JAMA. 2013 Mar 6;309(9):909-18. doi: 10.1001/jama.2013.1381.
9
Is viability imaging still relevant in 2012?2012年，存活成像是否仍具有相关性？
JACC Cardiovasc Imaging. 2012 May;5(5):550-8. doi: 10.1016/j.jcmg.2011.10.010.
10
CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials.CMR 成像评估冠心病导致慢性心室功能障碍患者的存活能力：前瞻性试验的荟萃分析。
JACC Cardiovasc Imaging. 2012 May;5(5):494-508. doi: 10.1016/j.jcmg.2012.02.009.
Zotero 插件